The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia
Abstract
Allogeneic mobilized peripheral blood progenitor cells instead of bone marrow are increasingly used to restore hematopoiesis after myeloablative therapy. Data supporting this important change of clinical practice are scarce. We therefore assigned patients with early leukemias to peripheral blood or bone marrow transplantation; the occurrence of acute and chronic graft versus host disease, survival, transplantation-related mortality, and relapse rates were compared. A total of 350 patients between 18 and 55 years of age with acute leukemias in remission or chronic myelogenous leukemia in first chronic phase were randomized to receive either filgrastim-mobilized peripheral blood progenitor cells or bone marrow cells from HLA-identical sibling donors after standard high-dose chemoradiotherapy. Neutrophil and platelet recovery occurred significantly faster after transplantation of peripheral blood progenitor cells than after bone marrow transplantation. Acute graft versus host disease of grades II-IV was significantly more frequent in recipients of peripheral blood progenitor cells than in recipients of marrow cells (52% vs 39%, odds ratio 1.74, 95% confidence interval 1.12-2.69, P =.013). The cumulative incidence of chronic graft versus host disease was 67% with peripheral blood progenitor cells and 54% with bone marrow cells (hazard ratio 1.67, 95% confidence interval 1.15-2.42, P =.0066). The estimated overall probability of survival at 2 years was 65% with either source of stem cells (hazard ratio 1.15, 95% confidence interval 0.79-1.67, P =.46). Disease-free survival, transplantation-related mortality at day 100, and relapse rates did not significantly differ between treatment arms. Peripheral blood is an equivalent source of hematopoietic stem cells compared with bone marrow if administered to patients with standard-risk leukemias. Long-term observation of patients with different diseases and stages of disease is necessary to ultimately define the role of both sources of stem cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GLUCKSBERG, H., STORB, R., FEFER, A., BUCKNER, C. D., NEIMAN, P. E., CLIFT, R. A., LERNER, K. G., & THOMAS, E. D. (1974) · Transplantation · doi:10.1097/00007890-197410000-00001 · Cited by 3,694
Chronic graft-versus-host syndrome in man
Shulman, H. M., Sullivan, K. M., Weiden, P. L., McDonald, G. B., Striker, G. E., Sale, G. E., Hackman, R., Tsoi, M.-S., Storb, R., & Donnall Thomas, E. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90380-0 · Cited by 2,406
Bensinger, W. I., Martin, P. J., Storer, B., Clift, R., Forman, S. J., Negrin, R., Kashyap, A., Flowers, M. E. D., Lilleby, K., Chauncey, T. R., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101183440303 · Cited by 962
Champlin, R. E., Schmitz, N., Horowitz, M. M., Chapuis, B., Chopra, R., Cornelissen, J. J., Gale, R. P., Goldman, J. M., Loberiza, F. R., Hertenstein, B., et al. (2000) · PubMed · doi:10.1182/blood.v95.12.3702 · Cited by 507
Self-citationPan, L., Delmonte, J. J., Jalonen, C., & Ferrara, J. (1995) · Blood · doi:10.1182/blood.v86.12.4422.bloodjournal86124422 · Cited by 501
Schmitz, N., Dreger, P., Suttorp, M., Rohwedder, E., Haferlach, T., Löffler, H., Hunter, A., & Russell, N. H. (1995) · Blood · doi:10.1182/blood.v85.6.1666.bloodjournal8561666 · Cited by 474
Self-citationNash, R., Pepe, M., Storb, R., Longton, G., Pettinger, M., Anasetti, C., Appelbaum, F., Bowden, R., Deeg, H., & Doney, K. (1992) · Blood · doi:10.1182/blood.v80.7.1838.1838 · Cited by 377
Atkinson, K., Horowitz, M., Gale, R., van Bekkum, D., Gluckman, E., Good, R., Jacobsen, N., Kolb, H., Rimm, A., & Ringden, O. (1990) · Blood · doi:10.1182/blood.v75.12.2459.2459 · Cited by 359
Powles, R., Mehta, J., Kulkarni, S., Treleaven, J., Millar, B., Marsden, J., Shepherd, V., Rowland, A., Sirohi, B., Tait, D., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02090-0 · Cited by 354
Sample size calculations for ordered categorical data
Whitehead, J. (1993) · Statistics in Medicine · doi:10.1002/sim.4780122404 · Cited by 297
Cited by
Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors
Anasetti, C., Logan, B. R., Lee, S. J., Waller, E. K., Weisdorf, D. J., Wingard, J. R., Cutler, C. S., Westervelt, P., Woolfrey, A., Couban, S., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203517 · Cited by 920
(2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.020 · Cited by 451
Locasciulli, A., Oneto, R., Bacigalupo, A., Socie, G., Korthof, E., Bekassy, A., Schrezenmeier, H., Passweg, J., Fuhrer, M., & on the behalf of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation (SAA-WP, B. (2007) · Haematologica · doi:10.3324/haematol.10075 · Cited by 330
Yakoub-Agha, I., Mesnil, F., Kuentz, M., Boiron, J. M., Ifrah, N., Milpied, N., Chehata, S., Esperou, H., Vernant, J.-P., Michallet, M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.0952 · Cited by 268
Metadata
- Authors
- Schmitz, N.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2002-04-30
- Volume
- 100
- Issue
- 3
- Pages
- 761-767
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2099306009
- Cited by
- 271
- References
- 14
- FWCI
- 11.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia. https://app.cochat.ai/papers/10.1182/blood-2001-12-0304
- The paper
- Schmitz, N. (2002). Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia. Blood. https://doi.org/10.1182/blood-2001-12-0304
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.